IL93941A - Retinoblastoma gene product antibodies or immunogenic fragments having specific binding affinity to the rbi protein and methods of detecting tumor cells - Google Patents

Retinoblastoma gene product antibodies or immunogenic fragments having specific binding affinity to the rbi protein and methods of detecting tumor cells

Info

Publication number
IL93941A
IL93941A IL9394190A IL9394190A IL93941A IL 93941 A IL93941 A IL 93941A IL 9394190 A IL9394190 A IL 9394190A IL 9394190 A IL9394190 A IL 9394190A IL 93941 A IL93941 A IL 93941A
Authority
IL
Israel
Prior art keywords
asp
antibody
lys
rbi
arg
Prior art date
Application number
IL9394190A
Other languages
English (en)
Other versions
IL93941A0 (en
Original Assignee
Canji Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canji Inc filed Critical Canji Inc
Publication of IL93941A0 publication Critical patent/IL93941A0/xx
Publication of IL93941A publication Critical patent/IL93941A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4736—Retinoblastoma protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cosmetics (AREA)
IL9394190A 1989-03-31 1990-03-29 Retinoblastoma gene product antibodies or immunogenic fragments having specific binding affinity to the rbi protein and methods of detecting tumor cells IL93941A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33208289A 1989-03-31 1989-03-31

Publications (2)

Publication Number Publication Date
IL93941A0 IL93941A0 (en) 1990-12-23
IL93941A true IL93941A (en) 1995-03-30

Family

ID=23296661

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9394190A IL93941A (en) 1989-03-31 1990-03-29 Retinoblastoma gene product antibodies or immunogenic fragments having specific binding affinity to the rbi protein and methods of detecting tumor cells

Country Status (15)

Country Link
EP (1) EP0390530B1 (fr)
JP (1) JPH04193900A (fr)
KR (1) KR0175658B1 (fr)
CN (1) CN1046759A (fr)
AT (1) ATE122723T1 (fr)
AU (1) AU638238B2 (fr)
CA (1) CA2013544C (fr)
DE (1) DE69019410T2 (fr)
FI (1) FI901618A7 (fr)
IE (1) IE63277B1 (fr)
IL (1) IL93941A (fr)
NO (1) NO179328C (fr)
NZ (1) NZ233147A (fr)
PT (1) PT93619A (fr)
ZA (1) ZA902425B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710255A (en) * 1992-07-14 1998-01-20 Canji, Inc. Characterization of a novel anti-p110RB monoclonal antibody
US5550020A (en) * 1994-07-08 1996-08-27 Visible Genetics Inc. Method, reagents and kit for diagnosis and targeted screening for retinoblastoma
US5545527A (en) * 1994-07-08 1996-08-13 Visible Genetics Inc. Method for testing for mutations in DNA from a patient sample
ATE423852T1 (de) * 1996-04-05 2009-03-15 Antonio Giordano Methoden zur diagnose und prognose von krebs
US5840506A (en) * 1996-06-05 1998-11-24 Thomas Jefferson University Methods for the diagnosis and prognosis of cancer
WO2004060346A2 (fr) 2002-12-30 2004-07-22 Angiotech International Ag Liberation de medicaments a partir d'une composition polymere a gelification rapide
TW200741009A (en) 2005-07-01 2007-11-01 Oncotherapy Science Inc Methods of modulating SMYD3 for treatment of cancer
CN102053150B (zh) * 2009-10-30 2013-07-17 上海交通大学医学院附属瑞金医院 一种人成骨肉瘤干细胞相关抗原标记物及其应用
CN121471352B (zh) * 2025-11-15 2026-07-07 北京中杉金桥生物技术有限公司 一种抗人rb蛋白单克隆单体及其应用、杂交瘤细胞株和试剂盒

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0398955B1 (fr) * 1988-01-21 1998-07-08 MASSACHUSETTS EYE & EAR INFIRMARY Diagnostic du retinoblastome

Also Published As

Publication number Publication date
EP0390530A1 (fr) 1990-10-03
FI901618A0 (fi) 1990-03-30
NO179328C (no) 1996-09-18
CA2013544A1 (fr) 1990-09-30
NO901461D0 (no) 1990-03-30
DE69019410D1 (de) 1995-06-22
IE63277B1 (en) 1995-04-05
KR0175658B1 (ko) 1999-03-20
FI901618A7 (fi) 1990-10-01
PT93619A (pt) 1990-11-20
ATE122723T1 (de) 1995-06-15
NO901461L (no) 1990-10-01
NO179328B (no) 1996-06-10
AU5246190A (en) 1990-10-04
IL93941A0 (en) 1990-12-23
AU638238B2 (en) 1993-06-24
EP0390530B1 (fr) 1995-05-17
CN1046759A (zh) 1990-11-07
NZ233147A (en) 1993-04-28
IE901179L (en) 1990-09-30
JPH04193900A (ja) 1992-07-13
ZA902425B (en) 1991-01-30
CA2013544C (fr) 2001-02-06
KR900013987A (ko) 1990-10-22
DE69019410T2 (de) 1995-10-05

Similar Documents

Publication Publication Date Title
AU601360B2 (en) Monoclonal antibodies and antigen for human non-small cell lung carcinomas
CN102869682B (zh) 单克隆抗体及其诊断用途
US20090023143A1 (en) Predicting agent for metastasis
PL219093B1 (pl) Kompozycja farmaceutyczna, kompozycja farmaceutyczna do zastosowania w leczeniu, czynnik do zastosowania w sposobie diagnozowania choroby, czynnik do zastosowania w sposobie oznaczania regresji, przebiegu lub rozpoczęcia choroby, cytolityczne lub wydzielające cytokinę komórki T, komórka gospodarza lub jej wyciąg, komórki z ekspresją związanego z nowotworem antygenu, kwas nukleinowy, cząsteczka zrekombinowanego DNA lub RNA, komórka gospodarza, białko lub polipeptyd, przeciwciało, produkt sprzęgania i zestaw do wykrywania ekspresji
JP2003523207A5 (fr)
US5591595A (en) Detection of complexes which include basement membrane components as diagnostic of cancer and other diseases
EP0390530B1 (fr) Anticorps contre un produit du gène du rétroblastome et ses utilisations
CA2605745A1 (fr) Anticorps de l'isoforme de l'antigene nucleaire des cellules proliferatives cancereuses specifiques (pcnacs) et leurs utilisations
JPH08506801A (ja) Ｃｄ４４エキソン６に対応するペプチド、そのペプチドに特異的な抗体、および、腫瘍診断にそれらの抗体を使用する方法
IE58590B1 (en) Monoclonal antibodies and antigens for human non-small cell lung carcinomas
EP0203552B1 (fr) Anticorps monoclonaux pour les carcinomes du poumon humain du type à cellules non petites
JPH0734741B2 (ja) ヒト腎臓がん抗原に対するモノクローナル抗体生産ハイブリドーマ細胞系
US6242204B1 (en) Methods of detecting non-small cell lung carcinoma and ovarian cancer
CN110036119B (zh) 卵巢癌生物标记及其应用
KR101415927B1 (ko) 항―ｔｍａｐ／ｃｋａｐ２ 항체를 포함하는 암의 예후 진단용 조성물
AU601680B2 (en) Monoclonal antibodies for human non-small cell lung carcinomas
US5541076A (en) Methods for determining the invasiveness of a bladder tumor
US5851830A (en) Luminal epithelial antigen
EP0710362B1 (fr) Procede de determination du pouvoir d'invasion des tumeurs vesicales
FI94291B (fi) Monoklonaalinen vasta-aine
EP4192876A1 (fr) Détection de mica et de micb à la surface de cellules à l'aide d'anticorps

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees